Mycoplasma Pneumonia

Mycoplasma pneumonia is an acute respiratory infection with pneumonia caused by Mycoplasma, which is mainly manifested as cough and fever. Mycoplasma pneumonia tends to occur in densely populated environments and can be spread through droplets and direct contact. Approximately 50% of young adults and 75% of elderly persons have serological evidence of the previous infection, and Mycoplasma pneumonia accounts for about 10% of all pneumonia cases. Smoking and low immunity are high-risk factors for the disease. Most patients have a good prognosis, some will develop severe pneumonia, and severe Mycoplasma pneumonia may lead to death.

Diagnosis of Mycoplasma Pneumonia

The relevant diagnosis methods for Mycoplasma pneumonia are as follows:

• Physical examination. Check basic physical signs such as body temperature, blood pressure, and heart rate. Auscultate the lungs for breath sounds and rales. Touch the neck and ears to check for swollen lymph nodes.
• Blood routine. Patients with Mycoplasma infection may have elevated neutrophils.
• Condensation test and complement fixation test. Two weeks after the onset, about two-thirds of the patients with Mycoplasma pneumonia tested positive for condensation. If the serum Mycoplasma IgM antibody concentration is greater than or equal to 1:64, or the antibody concentration in the recovery period has increased by 4 times, the diagnosis can be further confirmed. Due to the lag of the antibody test, it is unable to use a positive antibody as the only basis for diagnosis.
• Culture of Mycoplasma pneumoniae. It is the gold standard for the diagnosis of Mycoplasma pneumonia. Direct detection of Mycoplasma antigens in the respiratory tract can be used for early and rapid diagnosis, but its detection rate is extremely low, technical requirements are high, and it takes a long time.
• Nucleic acid diagnosis. The nucleic acid detection technology is fast and sensitive, and can be used for early diagnosis of Mycoplasma pneumonia. The nucleic acid test is currently a rapid diagnostic method to confirm Mycoplasma infection, which can be quickly detected by collecting nasopharyngeal swabs, sputum and other secretions.
• Imaging examination. Pulmonary imaging can be used to assist diagnosis and prognostic observation.

Advantages of Our Products

Creative Biogene's Mycoplasma pneumonia products are mostly test kits, mainly for nucleic acid diagnosis, and using real-time PCR technology to quantitatively detect Mycoplasma pneumoniae. Our kit contains complete reagent preparation and detailed operating instructions. It is simple and convenient, fast and efficient, and has good performance in sensitivity, accuracy and reproducibility.

Creative Biogene has accumulated years of experience in Mycoplasma pneumonia diagnosis. We promise to provide you with the best diagnostic products. You can choose us with confidence.

Please contact us for more details.

Reference

1. Gullsby K, et al. (2008). "Simultaneous Detection of Chlamydophila pneumoniae and Mycoplasma pneumoniae by Use of Molecular Beacons in a Duplex Real-Time PCR." Journal of clinical microbiology. 46.2:727-731.